Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. S. Hegde
Activity of Telavancin Against Heterogeneous Vancomycin-Intermediate Staphylococcus Aureus (hVISA) in Vitro and in an in Vivo Mouse Model of Bacteraemia
Journal of Antimicrobial Chemotherapy
Infectious Diseases
Microbiology
Pharmacology
Related publications
Heterogeneous Vancomycin-Intermediate Among Methicillin Resistant Staphylococcus Aureus
Medical Journal Armed Forces India
Medicine
Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus Aureus by Imipenem
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Successful Treatment of Vancomycin-Intermediate Staphylococcus Aureus Pacemaker Lead Infective Endocarditis With Telavancin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparison of E Test GRD and Vancomycin Screen Agar (BHI-V3 and BHI-V4) in Detection of Heteroresistant Vancomycin Intermediate Staphylococcus Aureus (hVISA).
The Professional Medical Journal
Exposure of Staphylococcus Aureus to Subinhibitory Concentrations of -Lactam Antibiotics Induces Heterogeneous Vancomycin-Intermediate Staphylococcus Aureus
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative Bactericidal Activities of Daptomycin and Vancomycin Against Glycopeptide-Intermediate Staphylococcus Aureus (GISA) and Heterogeneous GISA Isolates
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models Against Staphylococcus Aureus
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Efficacy of Combined Vancomycin and Fosfomycin Against Methicillin-Resistant Staphylococcus Aureus in Biofilms in Vivo
PLoS ONE
Multidisciplinary
Design and Syntheses of Highly Potent Teixobactin Analogues Against Staphylococcus Aureus, Methicillin-Resistant Staphylococcus Aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo
